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ABSTRACT
Objective The impact of inﬂammatory bowel disease
(IBD) on disability remains poorly understood. The World
Health Organization’s integrative model of human
functioning and disability in the International Classiﬁcation
of Functioning, Disability and Health (ICF) makes disability
assessment possible. The ICF is a hierarchical coding
system with four levels of details that includes over 1400
categories. The aim of this study was to develop the ﬁrst
disability index for IBD by selecting most relevant ICF
categories that are affected by IBD.
Methods Relevant ICF categories were identiﬁed
through four preparatory studies (systematic literature
review, qualitative study, expert survey and cross-
sectional study), which were presented at a consensus
conference. Based on the identiﬁed ICF categories,
a questionnaire to be ﬁlled in by clinicians, called the ‘IBD
disability index’, was developed.
Results The four preparatory studies identiﬁed 138
second-level categories: 75 for systematic literature
review (153 studies), 38 for qualitative studies (six focus
groups; 27 patients), 108 for expert survey (125 experts;
37 countries; seven occupations) and 98 for cross-
sectional study (192 patients; three centres). The
consensus conference (20 experts; 17 countries) led to
the selection of 19 ICF core set categories that were
used to develop the IBD disability index: seven on body
functions, two on body structures, ﬁve on activities and
participation and ﬁve on environmental factors.
Conclusions The IBD disability index is now available. It
will be used in studies to evaluate the long-term effect of
IBD on patient functional status and will serve as a new
endpoint in disease-modiﬁcation trials.
Inﬂammatory bowel disease (IBD), encompassing
Crohn’s disease and ulcerative colitis, are chronic
disabling disorders of the gastrointestinal tract
affecting 2.2 million people in Europe and 1.4
million people in the USA.
1
IBD is known to affect physical, psychological,
familial and social dimensions of life.
2 3 Speciﬁc
tools, such as the inﬂammatory bowel disease
questionnaire, have been developed to assess
quality of life in patients with IBD.
45However, in
contrast to other chronic diseases, there has been no
index available for evaluating decrements of func-
tion or disability for IBD to date.
67As the natural
history of IBD may alter all dimensions of func-
tioning, it would be valuable to have a practical
tool covering the entire spectrum of limitations in
functioning in patients with IBD.
89In this context,
it is also important to take into account the impact
of the patient’s environment, which may improve
or worsen his/her level of functioning.
< Additional supplementary
tables are published online only.
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Signiﬁcance of this study
What is already known about this subject?
< Inﬂammatory bowel disease (IBD) is a frequent
disorder known to affect physical, psycholog-
ical, familial, and social dimensions of life.
< Disability refers to the problems (objective) that
a patient may have in different areas or health
domains, whereas quality of life (subjective)
refers to how he/she feels about these
limitations and restrictions.
< There is no tool available for disability for IBD.
< The International Classiﬁcation of Functioning,
Disability and Health (ICF) provides a compre-
hensive and WHO standard framework to
classify and describe functioning and disability
in patients with any disease or health condition,
including IBD.
What are the new ﬁndings?
< The comprehensive ICF core set for IBD, which
is capable of capturing all speciﬁc aspects of
disability that describe what it means to live
with IBD, has been deﬁned.
< The brief ICF core set for IBD, which captures
the essence of the experience of patients with
IBD and is used to develop the IBD disability
index, has been deﬁned.
< The ﬁrst disability index for IBD (the IBD
disability index) is now available.
How might it impact on clinical practice in the
foreseeable future?
< The IBD disability index will be useful for clinical
practice, disease modiﬁcation trials and health
reporting in IBD.
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Inﬂammatory bowel diseaseThe International Classiﬁcation of Functioning, Disability and
Health (ICF) provides a comprehensive and World Health
Organization (WHO) standard framework to classify and
describe functioning, disability and health in patients with
any disease or health condition, including IBD.
10 The ICF is
a coding system of functioning items as the basic classiﬁcation
units, which are called categories.
10 The ICF includes more
than 1400 of these categories classiﬁed according to four
components. The problems associated with a disease may
involve body functions, body structures and activities and
participation. In addition, disability (or a decrement in func-
tioning) is the result of an interaction between underlying
health conditions and contextual factors, namely environmental
and personal factors. The ICF categories are hierarchically
arranged in four levels: the ﬁrst or chapter level is followed with
increasing speciﬁcity by the second, third and fourth levels. As
the ICF is the international standard for describing functioning
and disability it would be the appropriate tool to form the
basis for developing an instrument to evaluate the functioning
decrements in IBD.
The objective of this paper is to describe the evidence-based
process leading to the development of the ﬁrst disability index
for IBD based on the ICF.
METHODS
The development of the IBD disability index was a cooperative
effort of the International Programme to Develop New Indexes
for Crohn’s Disease group, the International Organization on
Inﬂammatory Bowel Disease, the International Society of
Physical and Rehabilitation Medicine, the Classiﬁcation,
Terminology and Standards team at WHO, and the ICF Research
Branch in collaboration with the WHO Family of International
Classiﬁcations Collaboration Centre in Germany (at the German
Institute of Medical Documentation and Information).
This development was divided into a preparatory phase, in
which information was gathered from four preparatory studies
(a systematic literature review, a qualitative study, an expert
survey and a cross-sectional study) and an international
consensus conference. Each preparatory study and the consensus
conference allowed the identiﬁcation of the most relevant
categories of ICF that are affected by IBD. The methodology
followed by the preparatory studies and the consensus confer-
ence was published by Peyrin-Biroulet et al in 2010.
2 In a ﬁnal
step, the ICF categories identiﬁed during the consensus confer-
ence were operationalised using the questions of the world
health survey (WHS) performed by WHO as a reference.
11
Preparatory studies
Systematic literature review
The systematic literature review, whose objective was to capture
the perspective of researchers, was performed in three steps: (1)
searches in databases (MEDLINE, EMBASE, PSYCINFO,
CENTRAL and CINAHL); (2) extraction of outcome parameters
included in the studies; (3) linkage of the concepts within the
outcome parameters with the ICF categories.
Eligibility criteria used in the present study were: (1) studies
published in English; (2) studies published between 1999 and
2009; (3) randomised controlled trials, clinical controlled trials,
cross-sectional studies, longitudinal observational studies or
qualitative studies; (4) studies with a population of 10 or more
patients; (5) studies with subjects 18 years of age and older; (6)
studies including patients with IBD, Crohn’s disease or ulcera-
tive colitis.
Qualitative study
The qualitative study using focus group methodology was
performed to identify relevant aspects of functioning as well as
environmental factors from the patient perspective. Focus group
sessions according to a topic guide including six open-ended
questions were performed at the Mayo Clinic (Rochester,
Minnesota, USA) from August to October 2009. The study
protocol has been approved by the appropriate institutional
review board. Each focus group included four to six adult
patients with IBD consecutively seen at the Mayo Clinic. All
patients had signed an informed consent form. Focus group
sessions were digitally recorded and transcribed verbatim. The
meaning condensation procedure was used for the data anal-
ysis.
12 The resulting meaningful concepts were linked to ICF
categories according to established linking rules.
13 The total
number of focus groups was determined by saturation, which is
deﬁned as the point during data collection at which two
consecutive interviews reveal no additional information.
Expert survey
A worldwide internet-based expert survey was performed to
collect relevant aspects of functioning as well as environmental
factors from the perspective of the health professionals involved
in the management of patients with IBD. Gastroenterologists,
nurses, psychologists, digestive surgeons, dieticians, social
workers and stoma therapists with at least 5 years of profes-
sional experience were asked to identify problems in functioning
and contextual factors relevant to patients with IBD using open-
ended questions. The survey was performed from February to
April 2010. All answers were linked to the ICF based on estab-
lished linking rules.
14 Absolute and relative frequencies of the
linked ICF categories were reported.
Cross-sectional study
The objective of the cross-sectional study was to describe
functioning and to identify environmental factors of patients
with IBD from the clinical perspective. The study took place in
three centres in France (Departments of Hepato-gastro-
ennterology of the University Hospitals of Lille, Nancy and Paris
(Saint-Louis)) from May to June 2010. The protocol was
approved by the appropriate French ethics committee. A 170-
category ICF checklist was used to collect data. In each centre,
all the data were recorded by one health professional involved in
the management of patients with IBD. All the patients included
in the study were 18 years of age or older, presented with
Crohn’s disease or ulcerative colitis and had signed an informed
consent form.
Detailed methods for each step have already been provided in
the literature.
14e20
Consensus conference
The consensus conference took place from 24 to 26 June 2010 at
the Guido Zäch Institute in Nottwil, Switzerland. Participants
were stratiﬁed by health profession and the country of origin
and then were randomly selected to ensure a balanced repre-
sentation of all important health professions and all WHO-
designated world regions. During the consensus conference, all
the participants were introduced to the ICF framework, classi-
ﬁcation structure and codes, and then the ICF categories relevant
for patients with IBD were identiﬁed in an iterative decision-
making process that included discussions and voting in working
groups and plenary sessions. The process was guided by
a member of the ICF research branch. The ICF categories most
frequently named in all four preparatory studies (so-called
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Inﬂammatory bowel diseasecandidate categories) made up the starting point of the decision-
making and consensus process. This process consisted of two
major activities. In the ﬁrst activity, the participants were asked
to select ICF categories to be included in a so-called compre-
hensive ICF core set for IBD. In the second activity, the partic-
ipants were requested to select the categories for the so called
brief ICF core set for IBD from the list of ICF categories already
included in the comprehensive ICF core set by means of a two-
round ranking exercise and a ﬁnal vote. The detailed method has
already been provided in the literature.
21
The comprehensive ICF core set is intended for use in clinical
practice, in settings in which a comprehensive assessment
is necessary. The brief core set captures the essence of the
experience of patients with IBD. It therefore serves as the
starting point for condition-speciﬁc research and basic clinical
documentation.
IBD disability index
Based on the ICF categories of the brief ICF core set for IBD,
a questionnaire was developed. One to two questions of the
questionnaire were used to operationalise each of the ICF cate-
gories of the brief ICF core set for IBD, and whenever possible
questions of the WHS were used. For other ICF categories for
which no WHS questions were available, the deﬁnitions
provided by the ICF were used to create the questions. The
questions addressed the severity of each problem of patients
with IBD in each functioning area described by the ICF cate-
gories of the brief ICF core set. Answers were given using a ﬁve-
point Likert scale (1, no to 5, extreme). The IBD disability index
was designed to be applied by an interviewer, but a self-reported
version may also be developed.
RESULTS
Preparatory studies
Systematic literature review
The literature database searches resulted in 9728 unique
abstracts, of which 2579 were randomly selected for analysis.
After a ﬁrst analysis on abstract and a second analysis on full
text, 153 studies met the inclusion criteria. The characteristics of
these 153 studies are shown in supplementary table 1, available
online only. Out of these 153 studies, 133 (86.9%) included 76
different outcomes measures (eg, disease classiﬁcations/indexes,
patient-reported outcome measures, clinical tests). Based on the
concepts contained in these outcome measures, 155 ICF
Table 1 Comprehensive ICF core set for IBD
ICF code and level
ICF category 1st 2nd 3rd 4th
Body functions (b) b130 Energy and drive functions
b134 Sleep functions
b152 Emotional functions
b1801 Body image
b28012 Pain in stomach or abdomen
b28016 Pain in joints
b430 Haematological system functions
b435 Immunological system functions
b515 Digestive functions
b525 Defecation functions
b530 Weight maintenance functions
b535 Sensations associated with the digestive system
b545 Water, mineral and electrolyte balance functions
b640 Sexual functions
b660 Procreation functions
b810 Protective functions of the skin
Body structures (s) s540 Structure of intestine
s770 Additional musculoskeletal structures related to movement
Activities and
participation (d)
d230 Carrying out daily routine
d5301 Regulating defecation
d570 Looking after one’s health
d7 Interpersonal interactions and relationships
d810ed839 Education
d840ed859 Work and employment
d920 Recreation and leisure
Environmental
factors (e)
e110 Products or substances for personal consumption
e1501 Design, construction and building products and technology for gaining access to facilities
inside buildings for public use
e310 Immediate family
e320 Friends
e355 Health professionals
e410 Individual attitudes of immediate family members
e420 Individual attitudes of friends
e425 Individual attitudes of acquaintances, peers, colleagues, neighbours and community members
e450 Individual attitudes of health professionals
e570 Social security services, systems and policies
e580 Health services, systems and policies
IBD, inﬂammatory bowel disease; ICF, International Classiﬁcation of Functioning, Disability and Health.
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Inﬂammatory bowel diseasecategories (including 75 second-level categories) were linked (see
supplementary table 2, available online only).
Qualitative study
A total of 27 participants was included in six focus groups.
Patients were men (n¼17) and women (n¼10), aged between 23
and 70 years (mean 44 years), with Crohn’s disease (n¼16) or
ulcerative colitis (n¼11). The percentage of new second-level
ICF categories identiﬁed after each focus group was 94% after
focus group 1, 12% after focus group 2, 24% after focus group 3,
7% after focus group 4 and 8% after focus group 5. Based on the
statements of the participants numerous aspects of functioning
as well as environmental factors were linked to 88 ICF categories
(including 38 second-level ICF categories) (see supplementary
table 3, available online only).
Expert survey
A total of 125 experts from 37 countries with various occupa-
tions (dieticians n¼24; gastroenterologists n¼44; nurses n¼17;
psychologists n¼9; colorectal-surgeons n¼17; social workers
n¼4; stoma therapists n¼10) participated in the worldwide
internet-based survey. The mean age of these experts was
46 years (SD 9.5; range 28e67). Additional demographic char-
acteristics are summarised in supplementary table 4, available
online only. Based on the statements of the participating experts
206 ICF categories (including 108 second-level categories) were
identiﬁed (see supplementary table 5, available online only).
Cross-sectional study
A total of 192 patients was included in this preparatory study.
Patients were men (n¼90; 46.9%) and women (n¼102; 53.1%),
aged between 18 and 75 years (with a mean (SD) of 36.7 (12.9)
years), with Crohn’s disease (n¼138; 71.9%) or ulcerative colitis
(n¼54; 28.1%). Disease duration ranged between 1 and 34 years,
with a mean (SD) of 10.4 (7.7) years. A total of 126 ICF cate-
gories (including 98 second-level categories) were identiﬁed (see
supplementary table 6, available online only).
Finally, the four preparatory studies identiﬁed 138 second-
level ICF categories as candidate categories for the ICF core sets
for IBD: 40 on body functions, 17 on body structures, 39 on
activities and participation and 42 on environmental factors.
The list of ICF categories ﬁnally presented at the conference to
the participants included 448 ICF categories at all levels.
ICF consensus conference
A total of 20 experts in the ﬁeld of IBD with various occupations
(dieticians n¼1; gastroenterologists n¼12; nurses n¼2;
psychologists n¼2; colorectal surgeons n¼1; social workers n¼1;
and stoma therapists n¼1) from 17 countries attended the
consensus conference. The iterative decision-making and
consensus process involved three working groups with six to
seven health professionals each. The process was facilitated by
the moderator of the plenary sessions, three working group
leaders and three working group assistants. The candidate ICF
categories identiﬁed in the four preparatory studies made up the
starting point of this process. The group decisions were
presented and discussed at several plenary sessions. The partic-
ipants of the conference decided on the ICF categories to be
included in the comprehensive and the brief ICF core set for IBD.
The comprehensive ICF core set for IBD includes 36 ICF
categories of all components of the classiﬁcation. It is made up
of 16 body functions (44.4%), two body structures (5.6%), seven
activities and participation categories (19.4%) and 11 environ-
mental factors (30.6%). Table 1 shows the ICF categories
included in the comprehensive ICF core sets for IBD.
Based on the comprehensive ICF core set for IBD the partic-
ipants of the conference decided in three ranking rounds on the
selection of the categories for the brief ICF core set. According to
a ﬁnal cut-off decision they selected 19 categories for the brief
ICF core set for IBD, which represents nearly 53% of the cate-
gories of the comprehensive ICF core set. Seven categories were
chosen from the component body functions, two from body
structures, ﬁve from activities and participation and ﬁve from
environmental factors, respectively (table 2).
IBD disability index
In line with the results of the consensus conference the IBD
disability index was established. In total, it contains 28
Table 2 Brief ICF core set for IBD
ICF code and level
ICF category 1st 2nd 3rd 4th
Body functions (b) b130 Energy and drive functions
b134 Sleep functions
b152 Emotional functions
b1801 Body image
b28012 Pain in stomach or abdomen
b515 Digestive functions
b525 Defecation functions
Body structures (s) s540 Structure of intestine
s770 Additional musculoskeletal structures related to movement
Activities and participation (d) d5301 Regulating defecation
d570 Looking after one’s health
d7 Interpersonal interactions and relationships
d810ed839 Education
d840ed859 Work and employment
Environmental factors (e) e110 Products or substances for personal consumption
e310 Immediate family
e355 Health professionals
e570 Social security services, systems and policies
e580 Health services, systems and policies
IBD, inﬂammatory bowel disease; ICF, International Classiﬁcation of Functioning, Disability and Health.
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Inﬂammatory bowel diseasequestions (ﬁgure 1). The ﬁrst question asks about the general
health of the patient. The next 17 questions address the ICF
categories of the brief ICF core set for IBD that correspond to the
components body functions, body structures and activities and
participation. The last 10 questions address the environmental
factors. As environmental factors can have either a positive or
a negative effect on the extent of disability, the questions are
paired. One question of each pair addresses the extent to which
the environmental factor, such as medication, represents a facil-
itator during the previous week, the other asks whether the
environmental factor was a barrier. For all 28 questions, the code
of the ICF category that they address is written.
DISCUSSION
In this paper, we describe the evidence-based process followed to
develop the ﬁrst disability index for IBD. IBD is a chronic
disabling condition.
2 8 Therefore, there was a need to develop
a speciﬁc instrument capable of evaluating disability in IBD. The
formal consensus process integrating evidence from four prepa-
ratory studies and expert knowledge at the ICF core set
conference for IBD led to the deﬁnition of a comprehensive and
a brief ICF core set for IBD. The comprehensive ICF core set for
IBD is capable of capturing all speciﬁc aspects of disability that
describe what it means to live with IBD. The brief ICF core set
for IBD was used to develop the IBD disability index that can be
used in studies to evaluate the long-term effect of IBD on
patient functional status and as a new endpoint in clinical trials
aimed at changing the clinical course of the disease. The ﬁnal
aim is to obtain a single number that represent the level of
disability and that will allow data comparison across healthcare
settings, countries, and at different time points. In the following
paragraphs we concentrate on the relevance of the 19 ICF
Figure 1 Inﬂammatory bowel disease
disability index.
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Inﬂammatory bowel diseasecategories included in the brief ICF core set for IBD that went
into the disability index.
Body functions, energy and drive functions (ICF code b130)
are frequently impaired in patients with IBD. The prevalence of
fatigue ranges from 41% to 48% in patients with IBD in
remission. Data are conﬂicting on whether fatigue severity is
proportional to disease severity or activity.
22 Ranjbaran et al
23
showed that patients with IBD have signiﬁcant sleep distur-
bance (b134 Sleep functions) even when their disease is not
active. As is the case with most chronic illnesses, there is
a higher rate of anxiety and depressive symptoms (b152
Emotional functions) in IBD than in the population at large.
24
Body image (b1801) is another ICF category in the compre-
hensive and brief ICF core sets for IBD. It is well known that
body image is negatively affected by surgery.
25 Importantly, not
only ileostomy but also an ileoanal pouch anal anastomosis can
have a negative impact on body image and cosmesis when
performed using an open surgical procedure.
26
Abdominal pain (b28012 Pain in stomach and abdomen) is
frequent in patients with IBD. Digestive functions (b515
Absorption of nutrients, tolerance to food, etc.) and defecation
functions (b525 Faecal continence, faecal consistency, frequency
of defecation, etc.) are also frequently impaired over the course
of IBD. Anorectal function appears to be altered in many
patients with Crohn’s disease even in the absence of macro-
scopic anorectal disease.
27 This may be due to histological
alterations in the enteric nervous system.
8
Following the selection process of body structures, structure
of the intestine (s540) and musculoskeletal structures (s770:
Additional musculoskeletal structures related to movement)
were included in the brief ICF core set for IBD. IBD are chronic,
progressive, destructive diseases. Crohn’s disease may lead to
bowel damage (stricture, ﬁstula, abscess) while ulcerative colitis
can be associated with mucosal lesions.
28 29 Ankylosing spon-
dylitis and rheumatoid arthritis, frequently associated with IBD,
can also lead to joint damage.
8
Regarding activities and participation, work and employment
(d840ed859) is the only category that has been widely assessed
in IBD2. Even though patients with IBD may attain a similar
level of education (d810ed839) to that of the general popula-
tion, students and young adults have to face missed school
time.
30 31 The participants of the conference also included
regulating defecation (d5301), looking after one’s health (d570),
and interpersonal interactions and relationships (d7) in the brief
ICF core set for IBD because they felt that these categories are
fundamental to describe the experience of living with IBD.
Five environmental factors were included in the brief ICF core
set for IBD. The participants agreed that health and social
systems, services and policies available for people with IBD in
each country are important factors acting as major facilitators or
barriers. The other environmental factors included in the brief
ICF core set addressed food and drugs as well as the support
provided by the family.
There are some limitations of the project up to the consensus
conference that should be mentioned. First, in the qualitative
study we performed six focus groups following the strategy of
saturation during data analyses. However, participants in
a seventh focus group could still have reported new themes and
concepts not yet reported. Second, the samples of the qualitative
and empirical studies consisted of persons coming from the USA
and France, respectively. This might have inﬂuenced the results
of both studies. To address this limitation and to have a cross-
cultural perspective of functioning and disability, in addition to
the ICF categories identiﬁed in the qualitative and empirical
studies, the results of the international expert survey and the
systematic review were also presented to the participants of the
international consensus conference.
The objective of the next phase will be to test and validate the
IBD disability index, and in particular to (1) assess the psycho-
metric properties (reliability, validity, and sensitivity to change)
of the index, (2) compare its sensitivity to change after treat-
ment with biological agents using a subgroup of patients and (3)
study whether the data collected based on the index reﬂects the
hypothesised single latent dimensiondfunctioningdand
whether the selected response options express a clearly deﬁned
ordered sequence.
In conclusion, a formal consensus process integrating evidence
from preparatory studies and expert opinion based on the ICF
framework and classiﬁcation led to the deﬁnition of the brief
ICF core set for IBD, which was then used to develop the ﬁrst
disability index for IBD. Since functioning and disability are
increasingly being taken into account in assessing the impact of
chronic diseases on the individual, as well as the effectiveness of
treatments on the natural course of the disease, having
a disability index for IBD will be useful for clinical practice,
disease modiﬁcation trials and health reporting in IBD. The fact
that this tool is grounded in the international standard language
of the ICF will ensure that the IBD disability index will be both
universally applicable and well accepted.
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